Arbiser JL - Search Results

1

Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism.

Cohen J, Huang S, Koczwara KE, Woods KT, Ho V, Woodman KG, Arbiser JL, Daman K, Lek M, Emerson CP Jr, DeSimone AM. Cohen J, et al. Among authors: arbiser jl. Cell Death Dis. 2023 Nov 16;14(11):749. doi: 10.1038/s41419-023-06257-2. Cell Death Dis. 2023. PMID: 37973788 Free PMC article.

2

Honokiol is a FOXM1 antagonist.

Halasi M, Hitchinson B, Shah BN, Váraljai R, Khan I, Benevolenskaya EV, Gaponenko V, Arbiser JL, Gartel AL. Halasi M, et al. Among authors: arbiser jl. Cell Death Dis. 2018 Jan 24;9(2):84. doi: 10.1038/s41419-017-0156-7. Cell Death Dis. 2018. PMID: 29367668 Free PMC article.

3

[No title available]

[No authors listed] [No authors listed] PMID: 34483341

4

Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment.

Muniraj N, Siddharth S, Shriver M, Nagalingam A, Parida S, Woo J, Elsey J, Gabrielson K, Gabrielson E, Arbiser JL, Saxena NK, Sharma D. Muniraj N, et al. Among authors: arbiser jl. Cell Death Discov. 2020 Sep 6;6:81. doi: 10.1038/s41420-020-00315-w. eCollection 2020. Cell Death Discov. 2020. PMID: 32963809 Free PMC article.

5

The antidepressant sertraline downregulates Akt and has activity against melanoma cells.

Reddy KK, Lefkove B, Chen LB, Govindarajan B, Carracedo A, Velasco G, Carrillo CO, Bhandarkar SS, Owens MJ, Mechta-Grigoriou F, Arbiser JL. Reddy KK, et al. Among authors: arbiser jl. Pigment Cell Melanoma Res. 2008 Aug;21(4):451-6. doi: 10.1111/j.1755-148X.2008.00481.x. Pigment Cell Melanoma Res. 2008. PMID: 18710373

6

Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo.

Shirazi F, Cohen C, Fried L, Arbiser JL. Shirazi F, et al. Among authors: arbiser jl. Lymphat Res Biol. 2007;5(4):233-6. doi: 10.1089/lrb.2007.1012. Lymphat Res Biol. 2007. PMID: 18370913

7

Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo.

Radi R, Huang C, Elsey J, Jung YH, Corces VG, Arbiser JL. Radi R, et al. Among authors: arbiser jl. Antioxidants (Basel). 2022 Apr 19;11(5):798. doi: 10.3390/antiox11050798. Antioxidants (Basel). 2022. PMID: 35624662 Free PMC article.

8

Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties.

Baker P, Huang C, Radi R, Moll SB, Jules E, Arbiser JL. Baker P, et al. Among authors: arbiser jl. Cells. 2023 Nov 30;12(23):2745. doi: 10.3390/cells12232745. Cells. 2023. PMID: 38067173 Free PMC article. Review.

9

AKT1 overexpression in endothelial cells leads to the development of cutaneous vascular malformations in vivo.

Perry B, Banyard J, McLaughlin ER, Watnick R, Sohn A, Brindley DN, Obata T, Cantley LC, Cohen C, Arbiser JL. Perry B, et al. Among authors: arbiser jl. Arch Dermatol. 2007 Apr;143(4):504-6. doi: 10.1001/archderm.143.4.504. Arch Dermatol. 2007. PMID: 17438183

10

Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.

Kang HB, Fan J, Lin R, Elf S, Ji Q, Zhao L, Jin L, Seo JH, Shan C, Arbiser JL, Cohen C, Brat D, Miziorko HM, Kim E, Abdel-Wahab O, Merghoub T, Fröhling S, Scholl C, Tamayo P, Barbie DA, Zhou L, Pollack BP, Fisher K, Kudchadkar RR, Lawson DH, Sica G, Rossi M, Lonial S, Khoury HJ, Khuri FR, Lee BH, Boggon TJ, He C, Kang S, Chen J. Kang HB, et al. Among authors: arbiser jl. Mol Cell. 2015 Aug 6;59(3):345-358. doi: 10.1016/j.molcel.2015.05.037. Epub 2015 Jul 2. Mol Cell. 2015. PMID: 26145173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page